Regenxbio Inc (NASDAQ: RGNX) is -46.35% lower on its value in year-to-date trading and has touched a low of $8.53 and a high of $28.80 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RGNX stock was last observed hovering at around $11.14 in the last trading session, with the day’s loss setting it -1.51%.
Currently trading at $9.63, the stock is -1.85% and -8.27% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.28 million and changing -13.55% at the moment leaves the stock -32.74% off its SMA200. RGNX registered -49.69% loss for a year compared to 6-month loss of -39.77%. The firm has a 50-day simple moving average (SMA 50) of $10.498 and a 200-day simple moving average (SMA200) of $14.31765.
The stock witnessed a -9.15% gain in the last 1 month and extending the period to 3 months gives it a -22.84%, and is -13.71% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.22% over the week and 7.57% over the month.
Regenxbio Inc (RGNX) has around 344 employees, a market worth around $412.45M and $84.33M in sales. Profit margin for the company is -283.19%. Distance from 52-week low is 12.83% and -66.56% from its 52-week high. The company has generated returns on investments over the last 12 months (-57.85%).
with sales reaching $23.45M over the same period.The EPS is expected to grow by 21.64% this year, but quarterly earnings will post -3.73% year-over-year. Quarterly sales are estimated to grow 5.56% in year-over-year returns.
Regenxbio Inc (RGNX) Top Institutional Holders
271.0 institutions hold shares in Regenxbio Inc (RGNX), with institutional investors hold 99.62% of the company’s shares. The shares outstanding are 49.55M, and float is at 44.84M with Short Float at 10.95%. Institutions hold 92.26% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 8.61 million shares valued at $100.73 million. The investor’s holdings represent 18.8252% of the RGNX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 5.11 million shares valued at $59.83 million to account for 11.1818 of the shares outstanding. The other top investors are REDMILE GROUP, LLC which holds 4.57 million shares representing 9.9924% and valued at over $53.47 million, while JPMORGAN CHASE & CO holds 6.5871 of the shares totaling 3.01 million with a market value of $35.25 million.
Regenxbio Inc (RGNX) Insider Activity
The most recent transaction is an insider sale by KARABELAS ARGERIS N, the company’s Director. SEC filings show that KARABELAS ARGERIS N sold 10,000 shares of the company’s common stock on Oct 01 ’24 at a price of $10.11 per share for a total of $0.1 million. Following the sale, the insider now owns 11286.0 shares.
Regenxbio Inc disclosed in a document filed with the SEC on Sep 03 ’24 that KARABELAS ARGERIS N (Director) sold a total of 10,000 shares of the company’s common stock. The trade occurred on Sep 03 ’24 and was made at $11.56 per share for $0.12 million. Following the transaction, the insider now directly holds 11286.0 shares of the RGNX stock.
Still, SEC filings show that on Aug 01 ’24, KARABELAS ARGERIS N (Director) disposed off 10,100 shares at an average price of $13.51 for $0.14 million. The insider now directly holds 11,286 shares of Regenxbio Inc (RGNX).
